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Abstract
Background: The CRISPR/Cas9 system provides bacteria and archaea with molecular immunity against invading
phages and conjugative plasmids. Recently, CRISPR/Cas9 has been used for targeted genome editing in diverse
eukaryotic species.
Results: In this study, we investigate whether the CRISPR/Cas9 system could be used in plants to confer molecular
immunity against DNA viruses. We deliver sgRNAs specific for coding and non-coding sequences of tomato yellow
leaf curl virus (TYLCV) into Nicotiana benthamiana plants stably overexpressing the Cas9 endonuclease, and
subsequently challenge these plants with TYLCV. Our data demonstrate that the CRISPR/Cas9 system targeted
TYLCV for degradation and introduced mutations at the target sequences. All tested sgRNAs exhibit interference
activity, but those targeting the stem-loop sequence within the TYLCV origin of replication in the intergenic region
(IR) are the most effective. N. benthamiana plants expressing CRISPR/Cas9 exhibit delayed or reduced accumulation
of viral DNA, abolishing or significantly attenuating symptoms of infection. Moreover, this system could
simultaneously target multiple DNA viruses.
Conclusions: These data establish the efficacy of the CRISPR/Cas9 system for viral interference in plants, thereby
extending the utility of this technology and opening the possibility of producing plants resistant to multiple viral
infections.
Keywords: Plant genome engineering, CRISPR/Cas9 system, Synthetic site-specific nucleases, Viral-mediated
genome editing, Virus resistance, Tomato yellow leaf curl virus, Tobacco rattle virus
Background
In bacteria and archaea, the clustered regularly inter-
spaced palindromic repeat (CRISPR)/ CRISPR-associated
(Cas) 9 (CRISPR/Cas9) system confers molecular im-
munity against nucleic acids of invading conjugative
plasmids or phages [1–6]. The CRISPR/Cas9 system has
recently been harnessed in diverse eukaryotic species, in-
cluding plants, for the purpose of targeted genome edit-
ing and regulation [7, 8]. The CRISPR/Cas9 molecular
immunity system comprises the Cas9 endonuclease of
Streptococcus pyogenes and a synthetic single guide RNA
(sgRNA), which directs the Cas9 endonuclease to a tar-
get sequence complementary to the 20 nucleotides pre-
ceding the protospacer-associated motif (PAM) NGG,
which is required for Cas9 activity [9, 10]. Thus,
engineering of the system for a user-selected target re-
quires only the addition of 20 nucleotides to the sgRNA
molecule, allowing facile targeted genome editing and
regulation. Furthermore, simultaneous targeting of sev-
eral genomic loci (multiplexing) is feasible using mul-
tiple sgRNAs [7].
Geminiviruses, a large family of plant DNA viruses,
cause severe crop losses and economic consequences
that threaten food security worldwide, especially in
underdeveloped regions like sub-Saharan Africa [11, 12].
Members of the Geminiviridae possess a twin icosahe-
dral capsid structure that encapsidates a circular single-
stranded DNA (ssDNA) genome between 2.3 and 3 kb
in length. Geminiviridae viruses replicate their genome
either by a rolling-circle amplification (RCA) mechanism
via a double-stranded DNA (dsDNA) replicative form
(similar to that of Φ174 phage), or by recombination-
mediated replication [13]. Geminiviruses do not encode
their own DNA polymerase, but instead reactivate S
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phase and the cellular machinery to facilitate replication
of their own genome [14]. Upon infection of plant cells,
the viral Rep protein binds to the origin of replication,
thereby initiating viral replication in the nucleus [15].
Based on their genome organization, host range, insect
vectors, and genome-wide pairwise sequence identity,
members of Geminiviridae are classified into seven gen-
era: Begomovirus, Mastrevirus, Curtovirus, Becurtovirus,
Eragrovirus, Turncurtovirus and Topocuvirus. Members
of the genus Begomovirus, which infect dicotyledonous
plants via whitefly transmission vectors, include bipartite
and monopartite viruses [16]. Bipartite viruses, such as
African cassava mosaic virus and cabbage leaf curl virus,
have genomes comprising two components (A and B)
that differ in sequence (except for the common region, a
200–250-bp sequence that is nearly identical) [14]. The
common region forms part of the highly conserved
intergenic region (IR), which contains the origin of repli-
cation and promoter sequences for RNA polymerase II
[17]. By contrast, monopartite viruses, such as tomato
yellow leaf curl virus (TYLCV), have a single genomic
component. A conserved nucleosome-free IR is present
in the minichromosome of all geminiviruses [17, 18].
TYLCV, a member of the genus Begomovirus, causes
widespread destruction of tomato crops worldwide [19].
TYLCV is a ssDNA virus, with a genome of approxi-
mately 2.7 kb [20, 21]. The genomic structure of TYLCV
(Fig. 1a) consists of six bi-directionally organized, par-
tially overlapping open reading frames (ORFs), with an
IR containing the origin of replication [15]. Disease
symptoms caused by TYLCV include chlorotic leaf mar-
gins; cupped, thick, and rubbery small leaves; significant
fruit abscission; and overall stunting of plants [20]. Con-
trol and management of the disease caused by TYLCV
have proven both challenging and expensive. Previous
approaches to developing disease resistance focused on
insecticides targeting the viral transmission vector, the
silverleaf whitefly (Bemicia tabaci) [16]. Breeding for re-
sistance has been equally challenging due to linkage be-
tween the resistance locus and genes associated with
poor fruit quality [22, 23]. Several attempts have been
made to engineer tomato plants that are resistant to
TYLCV, including over-expressing the viral capsid pro-
tein (CP) and C4 protein or the non-coding IR se-
quences [24]; the latter approach is based on the idea
that binding of the Rep protein to the origin of replica-
tion might interfere with viral replication. A synthetic
zinc finger protein has been used to block the repli-
cation protein (Rep, C1) of beet severe curly top
virus from binding to the origin of replication, result-
ing in virus resistance [25]. A similar approach was
applied to TYLCV [26, 27]. Nonetheless, there is cur-
rently no effective means of controlling or managing
TYLCV disease. Therefore, to increase the yield of
crops infected by this and related viruses, it will be
necessary to develop efficient technologies for conferring
viral resistance [28].
Targeted DNA mutagenesis using site-specific endonu-
cleases has been used against a variety of mammalian
DNA viruses [29]. Very recently, the CRISPR/Cas9 sys-
tem was used to target different mammalian viruses. For
example, this technology was used to efficiently eradicate
HIV proviral DNA from the host genome and prevent
HIV infection [30]. It was also used to disrupt the
hepatitis B virus, treat latent infection by Epstein-Barr
virus, and engineer the large genome of the herpes
simplex virus [31–34]. A recent report showed the
feasibility of targeting a eukaryotic RNA virus using
the CRISPR/Cas machinery [35]. In this work, we
demonstrate the use of CRISPR/Cas9 for in planta
viral interference against TYLCV. Both the TYLCV
ORFs and the IR sequence could be targeted for
cleavage and mutagenesis by the CRISPR/Cas9 sys-
tem. Targeting of the TYLCV genome resulted in sig-
nificant reduction or attenuation of disease symptoms.
Further, the CRISPR/Cas9 system was able to target
multiple virus sequences simultaneously. Therefore, it
may be generally possible to use the CRISPR/Cas9
system to develop plants that are resistant to TYLCV
and other DNA viruses.
Results
CRISPR/Cas9-mediated interference with TYLCV
In this study, we investigated whether the CRISPR/Cas9
system can be used in plants to impart molecular im-
munity against DNA viruses. To this end, we used our
recently developed system for genome editing, which in-
volves systemic delivery of sgRNA molecules via tobacco
rattle virus (TRV) into N. benthamiana plants overex-
pressing Cas9 endonuclease (NB-Cas9OE) [36]. We de-
signed sgRNAs specific for different TYLCV coding and
non-coding sequences (Fig. 1a), and inserted them into the
TRV RNA2 genome. Next, we delivered the sgRNAs via
agroinfection of TRV into NB-Cas9OE plants. Seven days
post-infiltration (dpi) with TRV, we challenged the NB-
Cas9OE plants with an infectious TYLCV clone via agroin-
fection (Fig. 1b) [37]. Ten days later, we isolated total RNA
and DNA from the NB-Cas9OE plant systemic leaves for
various molecular studies. To determine TYLCV titer, we
performed semi-quantitative PCR using primers encom-
passing the IR region (Table S1 in Additional file 1). The
titer was lower in samples co-infiltrated with sgRNA tar-
geting the IR region than in those infiltrated with TRV vec-
tor controls and TYLCV (Fig. 1c). TYLCV replicates
through a RCA mechanism that exploits the plant machin-
ery [38]. An RCA assay revealed that targeting of the IR
via the CRISPR/Cas9 system prevented accumulation of
the TYLCV genome (Fig. 1d). Because TYLCV is a ssDNA
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virus that is converted to dsDNA inside the plant cell nu-
cleus, interference with TYLCV replication by targeting
the IR within replicating viral dsDNA should significantly
reduce the accumulation of both the ssDNA and dsDNA
forms. To test for interference with TYLCV replication, we
performed dot blot assays. The results showed that the
titer of TYLCV in IR-sgRNA plants was lower than that of
the TRV vector control (Figure S1 in Additional file 2). In
addition, we validated our dot blot results by Southern
blotting, which confirmed that targeting the IR of TYLCV
prevented accumulation of both ssDNA and dsDNA
(Fig. 1e).
We further confirmed our findings by using a different
method for TYLCV inoculation, namely, the sap trans-
mission method (Additional file 3). Sap from young
leaves of TYLCV-infected wild-type N. benthamiana
plants was directly applied to N. benthamiana Cas9OE
plants 7 days after infection with TRV-sgRNA. DNA was
extracted from the systemic leaves after 21 days of sap
application and then subjected to different types of mo-
lecular analysis. Non-specific sgRNA (possessing no se-
quence similarity to the TYLCV genome; Supplementary
sequence 9 in Additional file 4) rather than an empty
TRV vector was used in the sap transmission experi-
ments. The RCA results revealed a reduction in TYLCV
genome accumulation in both samples treated with IR-
sgRNA or CP-IR-sgRNA compared with samples treated
with non-specific sgRNA or TYLCV alone (Figure S2a in
Additional file 2). To confirm the RCA results, we next
performed semi-quantitative PCR to amplify a 560-bp
fragment encompassing the TYLCV IR. The results re-
vealed lower amplification of TYLCV with specific
sgRNAs than with controls (Figure S2b in Additional file
2), thereby confirming the RCA results. Both the RCA
and semi-quantitative PCR assays are based on the amp-
lification of available TYLCV genome. To further con-
firm these data, we next performed Southern blotting,
which confirmed lower accumulation of TYLCV in the
presence of specific sgRNAs than in the presence of con-
trols (Figure S2c in Additional file 2).
CRISPR/Cas9 mediates targeted cleavage of the TYLCV
genome
We subsequently investigated whether the attenuated
replication of TYLCV was indeed due to targeted cleav-
age or modification of the genome, rather than simply to
interference with the replication machinery resulting
from binding by the CRISPR/Cas9 complex. To this end,
we employed T7EI and restriction site loss assays to con-
firm targeting and determine the efficiency of modifica-
tions within the selected sequences. The 20-nucleotide
target sequence of the IR of the TYLCV contains a recog-
nition sequence for SspI endonuclease at the predicted
cleavage site 3 bp upstream of the PAM sequence. We iso-
lated genomic DNA at 10 dpi with the TYLCV infectious
clone and PCR amplified a 560-bp fragment encompass-
ing the IR target sequence, which contains two additional
SspI sites (Supplementary sequence 1 in Additional file 4).
Complete SspI digestion of the wild-type sequence pro-
duced four fragments of 53, 92, 189, and 216 bp; targeted
modification of the IR sequence and subsequent repair via
non-homologous end joining eliminated the SspI site
within the IR, generating a 269-bp SspI-resistant band.
We observed the 269-bp band only in the IR-sgRNA sam-
ples, indicating successful targeted modification of the IR
by the CRISPR/Cas9 system (Fig. 2a). To confirm the
presence of indels, we cloned the 560-bp PCR amplicons
into the pJET 2.1 cloning vector and performed Sanger se-
quencing. Alignment of the sequencing reads of 300
clones indicated that 42 % of the clones carried targeted
modifications within the IR sequence (Fig. 2c; Table S2 in
Additional file 1). Furthermore, to determine whether tar-
geting ORFs could also mediate interference with TYLCV,
we designed sgRNAs targeting the CP and RCRII motif of
the Rep ORF. The T7EI assays and Sanger sequencing in-
dicated that different ORFs could be targeted for modifi-
cation to interfere with TYLCV accumulation (Fig. 2b, d;
Figure S3 in Additional file 2; Table S2 in Additional
file 1). We confirmed the results of the T7EI assays by per-
forming RCA and Southern blotting assays (Figures S4 and
S5 in Additional file 2). In nature, DNA viruses are
(See figure on previous page.)
Fig. 1 CRISPR/Cas9-mediated interference with accumulation of the TYLCV genome. a Genome organization of TYLCV. The six partially overlapping
ORFs are represented by black filled arrows, and the IR is represented by an open box. The three CRISPR/Cas9 targets are represented by
red arrowheads. The sequences of the three targets (IR, CP, and RCRII) are shown on the right. b Schematic representation of the
experimental design. Agrobacterium containing engineered tobacco rattle virus (TRV) with sgRNA specific for the TYLCV genome was
infiltrated into Cas9-expressing plants. TYLCV was subsequently infiltrated to Cas9OE plants harboring an established TRV infection. Samples were
collected at 10–21 days post-infiltration (dpi) for molecular analysis. c Semi-quantitative PCR of TYLCV genomic DNA. TYLCV infiltration into Cas9OE
plants harboring IR-sgRNA accumulated lower levels of TYLCV than plants infiltrated with the TRV empty vector. Actin genomic DNA from N. benthamiana
was used for normalization. d Assay for rolling-circle amplification (RCA) of the TYLCV genome in plant extracts. Accumulation of TYLCV genomic DNA in
plants harboring IR-sgRNA was lower than that in plants inoculated with TYLCV and the TRV empty vector. e Southern blot analysis of TYLCV genomic
DNA accumulation in Cas9OE plants. TYLCV genomic DNA was detected with a DIG-labeled probe against a 560-bp sequence within the IR
region. All six individual IR-sgRNA-harboring plants that were infiltrated with TYLCV showed lower accumulation of the TYLCV genome than
plants inoculated with the TRV empty vector and TYLCV. Arrowheads in (d, e) indicate the expected size of the TYLCV genome. DIG Digoxigenin,
M DNA size marker, NB N. benthamiana, PEBV pea early browning virus promoter, RE restriction enzyme
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transmitted by different means and vectors. Therefore, we
wondered whether our system was capable of targeting the
sap-transmitted TYLCV genome. DNA was extracted from
sap-transmitted TYLCV and used to infect N. benthami-
ana Cas9OE plants expressing IR-sgRNA, CP-IR-sgRNA,
or controls. The corresponding CP fragment (642 bp) from
CP-IR-sgRNA and the IR fragment (560 bp) from CP-IR-
sgRNA or IR-sgRNA were PCR amplified and subjected to
BsmBI (CP) and SspI (IR) recognition site loss assays. DNA
fragments resistant to BsmBI in CP amplicons and to SspI
in IR amplicons were detected in CP-IR-sgRNA samples
but not in controls (Figure S2d in Additional file 2). The
corresponding SspI-resistant fragment was also observed
in IR-sgRNA samples but not in controls (Figure S2e in
Additional file 2).
CRISPR/Cas9 system mediates specific and multiple
targeting of viral genomes
We next asked whether the CRISPR/Cas9 is capable of
mediating specific interference with TYLCV. Notably,
the RCRII motifs of the Rep ORFs of geminiviruses are
conserved at the amino acid level but variable at the nu-
cleotide level. To confirm that our RCRII-sgRNA tar-
geted only the TYLCV RCRII region and interfered
specifically with TYLCV genome replication, we co-
infiltrated another monopartite geminivirus, beet curly
top virus (BCTV) strain Worland (Supplementary se-
quence 7 in Additional file 4), along with the TYLCV-
RCRII-sgRNA. We tested for modifications of the RCRII se-
quences of both TYLCV and BCTV using T7EI assays. The
results confirmed that TYLCV-RCRII-sgRNA specifically
Fig. 2 CRISPR/Cas9-mediated targeted cleavage of the TYLCV genome. a Mutation analysis using a restriction site loss assay. The TYLCV IR
(560 bp) was analyzed for loss of the SspI recognition site at the targeted locus. The arrow indicates the presence of a 269-bp SspI-resistant DNA
fragment only in samples harboring IR-sgRNA, but not in samples harboring the TRV empty vector. b T7EI assay for detecting indels in the RCRII
domain of the TYLCV genome. The T7EI assay detected mutations only in RCRII PCR amplicons from plants infiltrated with TRV containing
RCRII-sgRNA, but not in plants infiltrated with TRV empty vector. DNA fragments A and B were resolved on a 2 % agarose gel and stained with
ethidium bromide. Arrows show the expected DNA fragments. c Alignment of reads from PCR amplicons encompassing the IR region, which were
subjected to Sanger sequencing. d Alignment of reads from the PCR amplicons encompassing the RCRII motif, which were subjected to Sanger
sequencing. The wild-type (WT) TYLCV sequences are shown at the top. The target sequence is shown in red, the SspI site is indicated by a line,
and the protospacer-associated motif (PAM) is indicated in green. This is followed by the various indels, which are indicated by the numbers to
the right of the sequence (−x indicates deletion of x nucleotides; +x indicates insertion of x nucleotides; and T > G indicates change of T to G).
Arrows indicate the expected sizes of the cleavage products
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targeted the TYLCV genome, but not the BCTV genome
(Fig. 3a). We confirmed that BCTV-RCRII-sgRNA tar-
geted the BCTV genome but not the TYLCV genome
(Fig. 3a). Sanger sequencing data confirmed the results of
T7EI assays with regard to specific targeting of each
genome (Fig. 3b, c).
Because the stem-loop sequence of the origin of repli-
cation in the IR is conserved in all geminiviruses, we in-
vestigated the possibility of targeting different viruses
with a single sgRNA. We designed an IR-sgRNA that
contains the invariant TAATATTAC sequence common
to all geminiviruses (Fig. 4a) [39] and tested this IR-
sgRNA against TYLCV and BCTV. Sanger sequencing
confirmed the presence of indels and targeted modifica-
tions in both viruses (Fig. 4b, c; Table S2 in Additional
file 1). Because monopartite and bipartite geminiviruses
share the same conserved stem-loop sequence in the ori-
gin of replication within the IR (Fig. 4a), we next tar-
geted a bipartite virus, the Merremia mosaic virus
(MeMV) (Supplementary sequence 8 in Additional file
4) [40]. Sanger sequencing confirmed that IR-sgRNA
specific to TYLCV but containing the invariant TAA-
TATTAC sequence targeted a similar sequence in the
MeMV genome (Fig. 4d; Table S2 in Additional file 1).
Thus, a single sgRNA is capable of targeting multiple
viruses.
The CRISPR/Cas9 system attenuates or represses TYLCV
symptoms
Interference with TYLCV replication by the CRISPR/
Cas9 machinery is predicted to eliminate or reduce
TYLCV symptoms, reminiscent of the CRISPR/Cas9 sys-
tem’s originally evolved function in natural immunity of
bacteria against phages. Accordingly, we assessed and
evaluated TYLCV symptoms in NB-Cas9OE plants ex-
pressing sgRNAs against TYLCV coding and non-coding
sequences. In these experiments, we challenged three
groups of NB-Cas9OE plants, which expressed sgRNAs
specific to the IR, CP, or Rep regions, with an infectious
TYLCV clone. NB-Cas9OE plants expressing sgRNA
Fig. 3 Specific targeting of different viral genomes. RCRII sgRNAs specific for TYLCV and BCTV sequences target only the TYLCV and BCTV
genomes, respectively. a T7EI assays showing specific targeting of the TYLCV or BCTV genomes. b Alignment of Sanger sequenced reads from
the TYLCV-targeted RCRII region. c Alignment of Sanger sequenced reads from the BCTV-targeted RCRII region. The various indels are indicated
by the numbers to the right of the sequences (−x indicates deletion of x nucleotides; +x indicates insertion of x nucleotides; and X > Y indicates
change of nucleotide X to nucleotide Y). Arrows indicate the expected sizes of the cleavage products. WT wild type
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targeting the IR exhibited significantly reduced TYLCV
symptoms relative to the TRV vector control (Figure S6
in Additional file 2; Table S2 in Additional file 1). More-
over, NB-Cas9OE plants expressing sgRNA targeting the
CP or Rep ORF also exhibited a reduction of TYLCV
symptoms, but the magnitude of this reduction was
smaller than that achieved by targeting the IR-sgRNA
(Figure S7 in Additional file 2; Table S2 in Additional
file 1). In a second set of experiments, we investigated
whether targeting more than one sequence of the
TYLCV genome would lead to greater reduction of
TYLCV symptoms. To test this, we co-infiltrated a pair
of TRV RNA2 genomes carrying sgRNAs targeting the
CP region and IR. Targeting two different sequences
did not have an additive effect on the reduction of
TYLCV symptoms (Figure S8 in Additional file 2; Table S2
in Additional file 1).
Because co-infiltration of two RNA2 genomes carrying
two different sgRNAs does not ensure the delivery of
both sgRNAs into a single cell (and their subsequent ac-
tivities against single molecules of the viral genome), we
multiplexed our sgRNA delivery using the recently de-
veloped polycistronic tRNA–gRNA (PTG) system [41].
Subsequently, to determine the activity of both gRNAs
in this system, we delivered a single RNA2 genome car-
rying both IR-sgRNA and CP-sgRNA. This TRV system
was capable of expressing two sgRNAs that can target
both IR and CP sequences. Restriction site loss assays
(Figure S9 in Additional file 2) and Sanger sequencing
confirmed the targeted modification of both IR and CP
sequences (Figure S10 in Additional file 2). Furthermore,
simultaneous targeting of two sequences by PTG-based
expression led to greater reduction of virus titer and re-
covery of disease symptoms in NB-Cas9OE plants (Figure
S11 in Additional file 2; Table S2 in Additional file 1).
Next, we performed Southern blotting to confirm
the absence or reduced accumulation of the TYLCV
genome in IR-CP-sgRNA infiltrated plants relative to
that in plants infiltrated with the vector control. The
molecular analyses showed a significant reduction in
viral genome levels when the IR and CP region were
simultaneously targeted for cleavage. This confirmed
the phenotypic data regarding the TYLCV symptoms
(Figure S12 in Additional file 2).
Discussion
The CRISPR/Cas9 system confers molecular immunity
in bacterial and archaeal species, enabling these
Fig. 4 Targeting of different geminivirus genomes using a single sgRNA. A single IR-sgRNA was capable of targeting the TYLCV, BCTV, and MeMV
genomes. a IR-sgRNA (upper sequence) identical to the TYLCV IR sequence but harboring mismatches with the BCTV and MeMV IR sequences
(blue) was used to target all three viral genomes. b–d Alignment of Sanger sequenced reads from the IR-targeted region in the TYLCV, BCTV, and
MeMV genomes showing the respective targeted modifications. The wild-type (WT) sequence is shown at the top (red) and the PAM is shown
in green
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prokaryotes to fend off viral infections [42]. In this
study, we demonstrated the portability of the CRISPR/
Cas9 system to plants, where it is capable of conferring
molecular immunity against invading DNA viruses. To
evaluate the feasibility of using CRISPR/Cas9-mediated
interference against DNA viruses in plants, we per-
formed TRV-mediated systemic delivery of sgRNAs into
NB-Cas9OE plants. Targeting of the coding and non-
coding sequences of TYLCV resulted in specific modifi-
cation of viral sequences, and subsequently attenuated
viral replication and accumulation. Because binding of
the CRISPR/Cas9 system to the IR can attenuate viral
replication, we investigated the presence and efficiency
of genomic modification at the IR. Our data demonstrate
considerable levels of genomic modification at the IR,
indicating that the Cas9 endonuclease was catalytically
active. However, it remains to be determined whether
binding of catalytically inactive Cas9 (dCas9) could
interfere with virus replication and accumulation.
We tested sgRNAs targeting the CP, the RCRII motif
of Rep, and the IR sequences, and compared their effi-
ciency to interfere with TYLCV. All sgRNAs were cap-
able of mediating targeted cleavage of the TYLCV
genome. Extensive molecular analysis using RCA, semi-
quantitative PCR, and Southern blotting assays revealed
that targeting the IR led to a significant reduction in
viral replication and accumulation relative to other
TYLCV targets. Targeting of CP and RCRII attenuated
symptoms to a lesser extent than targeting of the IR,
possibly because both CP and RCRII encode proteins,
and a small amount of protein may be sufficient for
TYLCV to complete its cycle and develop symptoms.
Furthermore, because the IR contains the stem-loop
invariant sequence (TAATATTAC) of the TYLCV IR,
occupation or modification of this region by Cas9 makes
it inaccessible to Rep and/or other binding proteins
responsible for viral replication.
Subsequently, we investigated whether the co-delivery
of multiple sgRNAs via the TRV system would have an
additive effect, leading to higher interference levels than
obtained with single sgRNAs. The results demonstrated
that targeting CP and IR using separate RNA2 genomes
reduced viral replication and accumulation to levels
similar to those obtained with a single sgRNA targeting
either the IR or CP. Although we did not observe any
additive effect on the accumulation of the TYLCV gen-
ome, this might be due to the nature of the TRV infection;
i.e., because the two sgRNAs are not made in the same
cell, they are unable to simultaneously cleave the TYLCV.
On the other hand, construction of a TRV RNA2 genome
containing multiple sgRNAs led to multiplexed editing in
single cells, resulting in an additive effect.
One important criterion for in planta viral interfer-
ence is specificity against particular viral strains. We
investigated the specificity of our CRISPR/Cas9-medi-
ated viral interference system using sgRNAs targeting
either TYLCV or BCTV. When we used sgRNA tar-
geting TYLCV sequences, only the TYLCV genome
was modified, whereas when we used sgRNA target-
ing the BCTV, only the BCTV genome sequence was
modified, demonstrating the specificity of interference.
Such specificity is of particular importance when targeting
newly evolved viral variants.
Engineered resistance of the plant host to viral infec-
tion might place selection pressure on the virus, leading
to generation of variants with better adaptation, e.g., by
altering the PAM tri-nucleotide sequence or abrogating
recognition of the target sequence by the CRISPR/Cas9
system. For example, TYLCV recombinant variants that
overcome resistance have emerged in Ty-I resistant
plants [22]. Because the CRISPR/Cas9 system targets
viral DNA for destruction, DNA repair can lead to the
generation of viral variants with different PAM se-
quences that can evade the activity of the CRISPR/Cas9
system. Moreover, because particular DNA sequences
(e.g., the IR) are key to viral replication, mutagenesis of
these sequences will lead to significant reduction in viral
replication [43]. To maintain the replication of a new
viral variant, the target sequence must mutate to escape
recognition by the CRISPR/Cas9 system, and the key
replication enzymes that bind to this sequence must also
mutate to recognize the new sequence. Targeting two
viral sequences for cleavage will lead to the destruction
of the viral genome, reducing the likelihood of DNA re-
pair and generation of infectious viral variants. The
emergence of variants can be combated through the de-
sign and application of sgRNA molecules specific for the
new variant sequences.
We subsequently tested whether the CRISPR/Cas9
system is capable of targeting multiple viral strains by
co-infiltration of sgRNAs targeting TYLCV, BCTV, and
MeMV. The results showed that it was possible to target
more than one virus with a single sgRNA. Recent work
demonstrated the feasibility of expressing several
sgRNAs simultaneously [41]. Such a system could be
used to express sgRNAs with specificity for multiple
DNA viruses, enabling engineering of plants resistant to
multiple viruses or viral strains. This strategy should be
effective in developing resistance to mixed infections. It
should be noted that when using TRV-mediated delivery
of sgRNAs targeting coding and noncoding sequences,
the CRISPR/Cas9 system resulted in efficient interfer-
ence of TYLCV. However, we observed less accumula-
tion of the TYLCV genome when empty TRV vector was
used in NB-Cas9OE plants challenged with TYLCV
compared with NB-Cas9OE plants challenged with
TYLCV but carrying no TRV vectors (Fig. 1d, e; Figure
S12 in Additional file 2). Therefore, we do not entirely
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exclude other contributing silencing factors caused by
the presence of TRV vector due to more complex phe-
nomena at play, which requires further studies.
In summary, CRISPR/Cas9-mediated virus interference
in plants has numerous important features, including: 1)
the ability to target multiple DNA viruses simultaneously
using a single sgRNA targeting a conserved sequence
preceding the PAM tri-nucleotide sequence; 2) the cap-
acity for multiplexed editing of single or multiple viruses
using multiple sgRNAs; 3) the potential to overcome re-
sistance by targeting newly evolved viral revertants with
new sgRNAs; 4) applicability to all plant DNA viruses;
and 5) applicability to all transformable plant species.
Establishing the efficacy and extending the utility of the
CRISPR/Cas9 system for viral interference in plants will
create a platform for dissecting natural resistance and
immune functions. At the same time, it will provide bio-
technologists with a powerful tool for producing crop
plants resistant to multiple viral infections.
Conclusions
The data presented here show that the CRISPR/Cas9
system can be used for targeted interference and cleav-
age of the TYLCV genome. Targeting the TYLCV IR led
to a significant reduction in TYLCV accumulation and
disease symptoms. CRISPR/Cas9-mediated interference
is virus strain-specific, and can therefore be used to tar-
get multiple viruses. Our results confirm the efficacy of
the CRISPR/Cas9 system for virus interference, provid-




To clone sgRNAs targeting the TYLCV genome in the
TRV RNA2 vector, we used a PCR-based restriction
ligation procedure. A fragment containing the 20-
nucleotide target sequence, the 84-bp Cas9 binding loop
for sgRNA, and a 7 T repeat (as a terminator) was
amplified by PCR. A forward primer containing an
XbaI recognition site, 20-nucleotide target sequence,
and 23-nucleotide Cas9-binding sgRNA scaffold was
used with a reverse primer containing an XmaI recog-
nition site to amplify a 116-bp PCR fragment. Primer
sequences are provided in Table S1 in Additional file 1.
The 116-bp PCR fragment of the sgRNA for each target
was cloned into the TRV RNA2 vector under the control
of the pea early browining virus promoter using the XbaI
and XmaI restriction enzymes. Sanger sequencing was
used to confirm all clone sequences.
Mutation detection by restriction site loss
To test for targeted modification in the TYLCV genome
by the CRISPR/Cas9 system, we subjected PCR products
encompassing the target sequence to the restriction site
loss assay. Genomic DNA was isolated from samples
collected at 10 or 15 dpi. A fragment flanking the target
region of TYLCV was PCR amplified using a specific
primer set and Phusion high-fidelity polymerase (Supple-
mentary sequence 1 in Additional file 4). DNA of PCR
products was gel purified, and 200 ng was subjected to re-
striction enzyme protection analysis to detect the presence
of indels. The digested products were separated on 2 %
agarose gel. The PCR product was cloned into the pJet2.1
vector and subjected to Sanger sequencing.
T7EI mutation detection assay
To determine and quantify the activity of the CRISPR/
Cas9 system on the TYLCV genome, we measured mu-
tations resulting from double strand break repair
through the non-homologous end joining pathway, as
described previously [36]. Briefly, genomic DNA was
prepared from samples collected at 10 and 15 dpi and
used as a template for PCR amplification of fragments
encompassing the target sequences (Supplementary
sequence 1 in Additional file 4). PCR amplicons were
denatured, renatured, and treated with T7EI. To cal-
culate the frequency of modification, the PCR ampli-
cons were cloned into the pJET2.1 cloning vector and
successful cloning was confirmed by colony PCR and
BglII restriction digestion of the extracted plasmids.
The percentage of modified clones was calculated after
Sanger sequencing.
RCA assay
Total genomic DNA extracted from plants was quanti-
fied using a NanoDrop spectrophotometer, adjusted to a
concentration of 50 ng/μl, and analyzed using the RCA
amplicon kit (GE Healthcare). Genomic DNA (50 ng)
was incubated for 3 min at 95 °C in sample buffer and
placed on ice for 5 min. Enzyme mix and reaction buffer
were added, and the samples were incubated at 30 °C for
18 h for amplification, followed by incubation at 65 °C
for 15 min to inactivate the enzyme. NcoI was added to
the samples and incubated for 1 h at 37 °C, and the
digested samples were resolved on 1 % agarose gels.
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NB-Cas9OE plants expressing IR-sgRNA. Figure S7. Reduction of TYLCV
symptoms in NB-Cas9OE plants expressing CP-gRNA or RCRII-gRNA.
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